Wesley Y. Yu

581 total citations
24 papers, 380 citations indexed

About

Wesley Y. Yu is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Wesley Y. Yu has authored 24 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Wesley Y. Yu's work include Nonmelanoma Skin Cancer Studies (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and Melanoma and MAPK Pathways (5 papers). Wesley Y. Yu is often cited by papers focused on Nonmelanoma Skin Cancer Studies (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and Melanoma and MAPK Pathways (5 papers). Wesley Y. Yu collaborates with scholars based in United States, Australia and Denmark. Wesley Y. Yu's co-authors include S. Grampp, Chun‐Ying Wu, Thomas Fuerst, Ying Lü, Claus‐Christian Glüer, M. Jergas, Bo Fan, Harry K. Genant, Lindy P. Fox and E Colţ and has published in prestigious journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology and Osteoporosis International.

In The Last Decade

Wesley Y. Yu

22 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wesley Y. Yu United States 9 152 95 65 63 54 24 380
T. Musella Italy 10 77 0.5× 52 0.5× 87 1.3× 89 1.4× 56 1.0× 14 388
G. Lehmann Germany 13 202 1.3× 113 1.2× 129 2.0× 89 1.4× 24 0.4× 43 574
Norman Heyden United States 7 177 1.2× 66 0.7× 164 2.5× 126 2.0× 65 1.2× 8 498
Steve Orme United Kingdom 13 57 0.4× 125 1.3× 51 0.8× 75 1.2× 55 1.0× 29 517
C. Vandepol United States 13 80 0.5× 136 1.4× 211 3.2× 54 0.9× 100 1.9× 20 782
Anastasia Dede Greece 8 237 1.6× 80 0.8× 127 2.0× 158 2.5× 45 0.8× 8 493
Bruno Sutter France 8 274 1.8× 102 1.1× 92 1.4× 107 1.7× 20 0.4× 22 402
F Bianchi Canada 11 261 1.7× 62 0.7× 173 2.7× 149 2.4× 52 1.0× 18 500
Hongliang Wu China 10 20 0.1× 48 0.5× 38 0.6× 25 0.4× 63 1.2× 25 263

Countries citing papers authored by Wesley Y. Yu

Since Specialization
Citations

This map shows the geographic impact of Wesley Y. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley Y. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley Y. Yu more than expected).

Fields of papers citing papers by Wesley Y. Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley Y. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley Y. Yu. The network helps show where Wesley Y. Yu may publish in the future.

Co-authorship network of co-authors of Wesley Y. Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley Y. Yu. A scholar is included among the top collaborators of Wesley Y. Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley Y. Yu. Wesley Y. Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carroll, Bryan T., Clara Curiel‐Lewandrowski, Emily Y. Chu, et al.. (2025). Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision. Journal of the American Academy of Dermatology. 92(5). 1112–1114.
2.
Yu, Wesley Y., Lisbet Rosenkrantz Hölmich, Iva Johansson, et al.. (2025). CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features. Journal of the American Academy of Dermatology. 94(2). 661–663.
3.
Trapp, J. M., et al.. (2024). Diet of schistosome vectors influences infection outcomes. Ecosphere. 15(11). 2 indexed citations
4.
Yu, Wesley Y., et al.. (2024). Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP). Annals of Surgical Oncology. 32(4). 2748–2755. 1 indexed citations
5.
Tripathi, Raghav, Graham Fowler, Dale Han, et al.. (2023). A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. Annals of Surgical Oncology. 30(7). 4321–4328. 3 indexed citations
6.
Hornick, Noah I., et al.. (2022). A Novel Potential Role for Monocytes Revealed by Single Cell Analysis of Immunotherapy Induced Immune Related Adverse Events. Cancers. 14(21). 5407–5407. 5 indexed citations
7.
Yu, Wesley Y., E. Ricky Chan, John J. Pink, et al.. (2021). Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma. Journal of Investigative Dermatology. 141(7). 1802–1809. 7 indexed citations
8.
Yu, Wesley Y., Brian Lu, Roy C. Grekin, et al.. (2019). Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire. Dermatologic Surgery. 46(3). 327–334. 7 indexed citations
9.
Yu, Wesley Y., et al.. (2019). Cranial neuropathies as the presenting symptom of cutaneous squamous cell carcinoma. JAAD Case Reports. 5(12). 1037–1040. 2 indexed citations
10.
Yu, Wesley Y., Timothy G. Berger, Jeffrey P. North, Zoltán Lászik, & Jarish N. Cohen. (2019). Expression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts. Journal of the American Academy of Dermatology. 81(5). 1127–1133. 3 indexed citations
11.
Yu, Wesley Y., Paul Salmon, Jason E. Thuener, & Jeremy S. Bordeaux. (2019). Mohs Surgery for Advanced Tumors of the Scalp. Dermatologic Surgery. 45(2). S110–S117. 4 indexed citations
12.
Nosrati, Adi, Wesley Y. Yu, Joseph McGuire, et al.. (2018). Outcomes and Risk Factors in Patients with Multiple Primary Melanomas. Journal of Investigative Dermatology. 139(1). 195–201. 15 indexed citations
13.
Yu, Wesley Y. & Maria L. Wei. (2018). Suction Blisters. JAMA Dermatology. 155(2). 237–237. 1 indexed citations
14.
Yu, Wesley Y., Jeffrey P. North, Timothy H. McCalmont, & Kanade Shinkai. (2018). Wong-type dermatomyositis during anti–PD-1 therapy. JAAD Case Reports. 4(10). 1049–1051. 8 indexed citations
15.
Yu, Wesley Y., et al.. (2016). Papular acantholytic dyskeratosis of the vulva associated with familial Hailey-Hailey disease. Clinical and Experimental Dermatology. 41(6). 628–631. 12 indexed citations
16.
Ruben, Beth S., et al.. (2015). Generalized benign cutaneous reaction to cytarabine. Journal of the American Academy of Dermatology. 73(5). 821–828. 14 indexed citations
17.
Yu, Wesley Y., Tina Bhutani, R.K. Chaganti, et al.. (2014). Sweet heart: A case of pregnancy-associated acute febrile neutrophilic dermatosis with myopericarditis. JAAD Case Reports. 1(1). 12–14. 8 indexed citations
18.
Yu, Wesley Y. & Lawrence M. Tierney. (2014). HCC without cirrhosis metastasizing to the clivus. International Cancer Conference Journal. 4(3). 181–183. 2 indexed citations
19.
Limapichat, Walrati, Wesley Y. Yu, Emma Branigan, Henry A. Lester, & Dennis A. Dougherty. (2012). Key Binding Interactions for Memantine in the NMDA Receptor. ACS Chemical Neuroscience. 4(2). 255–260. 39 indexed citations
20.
Yu, Wesley Y., Claus‐Christian Glüer, S. Grampp, et al.. (1995). Spinal bone mineral assessment in postmenopausal women: A comparison between dual X-ray absorptiometry and quantitative computed tomography. Osteoporosis International. 5(6). 433–439. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026